drugset / Trial / NCT04500275

Topical Vancomycin Over Sternal Edge in Cardiac Surgery

NCT04500275

Phase 4 Completed 360 enrolled National Cheng-Kung University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

This is a single-blind 1:1 randomized controlled trial based on the hypothesis that topical application of vancomycin paste over sternum edge is safe and can reduce sternal wound infection after elective cardiac surgery. Vancomycin paste will be prepared using 2.5 g of vancomycin mixed with 2 ml normal saline. Vancomycin paste as control or 2 ml normal saline as placebo will be spread on sternal edge immediately after sternotomy and before sternal closure. The safety of Vancomycin paste over sternum edge will be assessed according to postoperative serum Vancomycin exposure and potential side effects such as renal toxicity or bacterial resistance. Effect of topical Vancomycin on incidence of postoperative sternal wound infection will be assessed on postoperative 7, 30, and 90 days.

Timeline

Start
2020-07-01
Primary completion
2025-03-31
Completion
2025-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified 5 g Topical

Indications

No indication recorded.